Literature DB >> 3891700

Pelvic inflammatory disease and its sequelae in adolescents.

A E Washington, R L Sweet, M A Shafer.   

Abstract

Pelvic Inflammatory Disease (PID) is the most common serious complication of sexually transmitted diseases (STDs). Each year over one million women in the United States experience an episode of PID, with approximately 16-20% of cases occurring in teenagers. Acute PID increases a woman's risk for recurrent PID, chronic pelvic pain, infertility, and ectopic pregnancy. Recent reports indicating that PID rates are rising and are highest among adolescent females aged 15-19 underscore the need to remain current on the clinical as well as the epidemiologic aspects of PID. We present such an update in this article. Trends in incidence and key risk factors are discussed; besides adolescence itself and STD, other important categories of risk factors include sexual activity, contraceptive method, and previous episode(s) of PID. The polymicrobial nature of PID is discussed along with an analysis of the role of specific organisms, such as Chlamydia trachomatis, Neisseria gonorrhoeae, anaerobic and aerobic bacteria, and mycoplasmas in PID. Early diagnosis and the institution of appropriate treatment regimens are essential to the prevention of PID's devastating sequelae. Clinicians must maintain a high index of suspicion for the wide range of clinical presentations associated with PID and be prepared to provide effective management, including proper evaluation and prompt treatment of sexual partners.

Entities:  

Keywords:  Adnexal Effects; Adnexitis; Adolescent Pregnancy; Adolescents; Adolescents, Female; Age Factors; Bacterial And Fungal Diseases--etiology; Biology; Chlamydia; Demographic Factors; Diseases--etiology; Examinations And Diagnoses; Fertility; Genital Effects, Female; Genitalia; Genitalia, Female; Gonorrhea; Infections--etiology; Literature Review; Pelvic Infections--etiology; Pelvic Inflammatory Disease; Physiology; Population; Population Characteristics; Population Dynamics; Reproductive Behavior; Reproductive Tract Infections; Sexually Transmitted Diseases; Treatment; Urogenital Effects; Urogenital System; Youth

Mesh:

Year:  1985        PMID: 3891700     DOI: 10.1016/s0197-0070(85)80067-x

Source DB:  PubMed          Journal:  J Adolesc Health Care        ISSN: 0197-0070


  9 in total

1.  Prevalence of sexually transmitted diseases in juvenile prostitutes and street youth.

Authors:  A C Rouget; J K Mah; R A Lang; M R Joffres
Journal:  Can J Infect Dis       Date:  1994-01

2.  Screening for Chlamydia trachomatis in adolescent males: a cost-based decision analysis.

Authors:  A G Randolph; A E Washington
Journal:  Am J Public Health       Date:  1990-05       Impact factor: 9.308

Review 3.  Magnetic resonance imaging of acquired disorders of the pediatric female pelvis other than neoplasm.

Authors:  Mougnyan Cox; Sharon W Gould; Daniel J Podberesky; Monica Epelman
Journal:  Pediatr Radiol       Date:  2016-05-26

4.  Cost effectiveness analysis of azithromycin and doxycycline for Chlamydia trachomatis infection in women: A Canadian perspective.

Authors:  F Marra; C A Marra; D M Patrick
Journal:  Can J Infect Dis       Date:  1997-07

5.  Socioeconomic differences in sexually transmitted disease rates among black and white adolescents, San Francisco, 1990 to 1992.

Authors:  J M Ellen; R P Kohn; G A Bolan; S Shiboski; N Krieger
Journal:  Am J Public Health       Date:  1995-11       Impact factor: 9.308

6.  Measuring adolescent sexual behaviors and related health outcomes.

Authors:  L Morris; C W Warren; S O Aral
Journal:  Public Health Rep       Date:  1993       Impact factor: 2.792

Review 7.  Pelvic inflammatory disease. Current approaches.

Authors:  B Romanowski
Journal:  Can Fam Physician       Date:  1993-02       Impact factor: 3.275

8.  Chlamydia trachomatis: a genital infection of particular concern to the young.

Authors:  A V Pavilanis
Journal:  Can Fam Physician       Date:  1987-08       Impact factor: 3.275

Review 9.  Chlamydia trachomatis in adolescents and adults. Clinical and economic implications.

Authors:  C A Marra; D M Patrick; R Reynolds; F Marra
Journal:  Pharmacoeconomics       Date:  1998-02       Impact factor: 4.981

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.